Abstract
To describe the setting, duration, and costs of induction and consolidation chemotherapy for adults with newly-diagnosed acute myeloid leukemia (AML), who are candidates for standard induction chemotherapy, in the US. Adults newly-diagnosed with AML who received standard induction chemotherapy in an inpatient setting were identified from the Truven Health Analytics MarketScan (2006-2015) and SEER-Medicare (2007-2011) databases. Patients were observed from induction therapy start to the first of hematopoietic stem cell transplant, 180 days after induction discharge, health plan enrollment/data availability end, or death. Induction and consolidation chemotherapy were identified using Diagnosis-Related Group codes (chemotherapy with acute leukemia) or procedure codes for AML chemotherapy administration. AML treatment episode setting (inpatient or outpatient), duration, and costs (2015 USD, payers' perspective) were described for commercially insured patients and Medicare beneficiaries. In total, 459 commercially insured patients and 563 Medicare beneficiaries (mean age = 54 and 66 years; 53% and 54% male; respectively) were identified. For induction therapy, mean costs were $145,189 for commercially insured patients and $85,734 fo...Continue Reading
References
Sep 30, 1999·The New England Journal of Medicine·B LöwenbergA Burnett
Jul 19, 2002·Archives of Internal Medicine·Joseph MenzinRajiv Mallick
Aug 15, 2002·Blood·D Gary Gilliland, James D Griffin
Dec 4, 2003·Cancer Control : Journal of the Moffitt Cancer Center·Ramalingam Rathnasabapathy, Jeffrey E Lancet
Apr 3, 2004·Cancer Treatment Reviews·Alberto RedaelliChris L Pashos
Oct 5, 2006·Cancer·Barbara Deschler, Michael Lübbert
Nov 14, 2007·Journal of Cancer Research and Therapeutics·N UdayakumarR Muthuselvan
Nov 15, 2008·Blood·Gunnar JuliussonMartin Höglund
May 20, 2009·Cancer·Shabbir M H AlibhaiJoseph Brandwein
Dec 17, 2009·European Journal of Haematology·Tom MøllerLars Kjeldsen
Mar 12, 2011·Haematologica·Roland B WalterElihu H Estey
Jan 13, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Benjamin M CraigChristopher R Cogle
May 17, 2013·Applied Health Economics and Health Policy·Juliana MeyersKeith L Davis
Jun 27, 2013·Nature Reviews. Clinical Oncology·Christopher S Hourigan, Judith E Karp
Dec 4, 2014·Cancer·Areej R El-JawahriJennifer S Temel
Sep 12, 2015·JAMA Oncology·Jennifer E VaughnRoland B Walter
Nov 17, 2015·Expert Review of Hematology·Amer M ZeidanB Douglas Smith
Dec 15, 2015·Blood·Eytan M Stein, Martin S Tallman
Apr 14, 2016·Blood·Daniel A ArberJames W Vardiman
Jul 14, 2016·Leukemia Research Reports·Antonio M Almeida, Fernando Ramos
Nov 29, 2016·JAMA : the Journal of the American Medical Association·Areej El-JawahriJennifer S Temel
Dec 15, 2016·Current Medical Research and Opinion·William IrishMark Shapiro
Feb 2, 2017·Current Treatment Options in Oncology·Xavier Thomas, Caroline Le Jeune
Mar 7, 2017·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jaime M PreusslerDavid J Vanness
Sep 23, 2018·Health and Quality of Life Outcomes·Eytan M SteinGeorge J Joseph
Citations
Nov 2, 2018·PharmacoEconomics·Eytan SteinGeorge Joseph
Dec 27, 2018·Current Opinion in Hematology·Anna B HalpernElihu H Estey
Aug 21, 2018·Journal of Medical Economics·May HagiwaraThomas E Delea
Dec 24, 2018·European Journal of Haematology·James D GriffinCat N Bui
Jun 5, 2019·Expert Review of Hematology·Jan Philipp BewersdorfAmer M Zeidan
Apr 14, 2020·Journal of Managed Care & Specialty Pharmacy·Bhavik J PandyaRolin L Wade
Mar 20, 2020·Journal of Medical Economics·Kathleen F VillaArthur C Louie
Jul 10, 2020·Journal of Medical Economics·Crystal WatsonArie Barlev
Nov 22, 2019·JNCI Cancer Spectrum·Lih-Wen MauEllen Denzen
Sep 15, 2020·Leukemia & Lymphoma·Anna B HalpernRoland B Walter
Oct 8, 2020·Current Oncology Reports·Luis Antonio Meillon-Garcia, Roberta Demichelis-Gómez
Dec 11, 2020·Leukemia & Lymphoma·Liqing NingYimei Que
Nov 23, 2019·Leukemia Research·Connor WillisDavid Stenehjem
Sep 16, 2021·Blood Advances·Jan Philipp BewersdorfAmer M Zeidan
Dec 17, 2021·Leukemia & Lymphoma·Scott F HuntingtonEric M Ammann